TRANSPARENCY RX CORP

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2023

Legal Domicile

Principal Officer

JOESPH SHIELDS

Phone

9732707615

Tax Period

2024-01-01 to 2024-12-31

TRANSPARENCY RX CORP, founded in 2023, is a small nonprofit in the Community Improvement sector that reported $616K in total revenue in fiscal year 2024. Revenue surged 23% from the prior year, signaling strong growth momentum. Expenses of $703K exceeded revenue, resulting in a 14% operating deficit.

Mission

Accelerate affordable drug pricing and foster positive changes with the prescription drug market and pharmacy supply chain. Promote local, regional and national relationships for the interchange of ideas and dissemination of material related to pharmacy benefit managers, through transparent platforms an affordable drug pricing. Provide educational and professional growth opportunities. Foster positive relations in health care, medicine and the pharmacy benefit and pharmaceutical supply chain.

Program Service Accomplishments

Program 1

Issue education and legislation

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $615,500

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $615,500

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $40,837

Other Expenses $702,857

TOTAL EXPENSES $702,857

Year-over-Year Comparison

	2024	2023	Change
Revenue	$615,500	$500,000	+0.2%
Expenses	$702,857	$388,267	+0.8%
Net Income	$-87,357	$111,733	-1.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOSEPH SHIELDS	PRESIDENT	20.00	Officer Director	$0	$0	$0
GREG LYNK	TREASURER	1.00	Officer Director	$0	$0	$0
KHALID PITTS	SECRETARY	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$615,500	$702,857	$24,476	$-87,357
2023	$500,000	$388,267	$111,833	$111,733